NASDAQ:AUTL

Autolus Therapeutics Stock Predictions

etoro logo Buy AUTL
*Your capital is at risk
$1.62
-0.130 (-7.43%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

AUTL Prediction Chart

AUTL Predictions History

Latest community submissions for AUTL.
Predictor Target Session Target Price Result Direction Accuracy Score
Jan 5, 2026 $1.82 -2.45% $1.86 V 98.08% 1
Jan 5, 2026 $1.84 -1.53% $1.86 V 99.00% 2
Jan 5, 2026 $1.65 -11.76% $1.86 V 88.71% 1
Jun 24, 2025 $2.18 -1.56% $2.27 X 95.84% 0
Jun 24, 2025 Bullish $2.27 V 1
May 21, 2025 $1.48 -3.55% $1.47 V 99.62% 5
May 21, 2025 $1.50 -2.22% $1.47 V 98.23% 1
May 21, 2025 Bullish $1.47 X 0
Jan 27, 2025 $2.31 -2.69% $2.26 V 97.95% 1
Jan 27, 2025 $2.33 -1.68% $2.26 V 96.89% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for AUTL with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT AUTOLUS THERAPEUTICS PLC
Autolus Therapeutics
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which is in a Phase 1 clinical trial in pediatric patients with relapsed or refractory ALL; AUTO4, a program...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE